ABOUT THE PRODUCT
AlphaVax’s core technology – the alphavirus vector platform – is a proprietary system for delivering genetic material to stimulate targeted immune responses. This platform is designed for rapid vaccine development and offers the potential for broad applicability across various infectious diseases and cancer therapies.
Information is owner-confirmed
Last updated 3 weeks ago
Price range
Other products/services from AlphaVax
Vaccine Development Services
Biotechnology
N/A
AlphaVax
United States (US)